Abstract
Papillomaviruses (PVs) are a group of small DNA viruses that, with around 350 million years of evolution, acquired the capacity of infecting a broad range of vertebrates, including humans. To date, more than 300 PV types have been isolated. Viruses that have a long common evolutionary history with their host typically cause unapparent infections. However, in some Alpha-PV infections, lesions become apparent and may cause benign proliferative disorders or even malignant proliferative lesions of the cervix, vulva, vagina, anus, penis, and oropharynx. The incongruence observed between the topology of the phylogenetic tree of Alpha-PVs and that of their hosts suggests that virus-host codivergence is not the only evolutionary force that has driven the progression of PVs. The integration of the precursors of E5, E6, and E7 on the genome of the ancestral Alpha-PV was important and made the colonization of new niches and the emergence of carcinogenic types possible.
References
1.
Bravo
IG
, de Sanjosé
S
, Gottschling
M
. The clinical importance of understanding the evolution of papillomaviruses
. Trends Microbiol
. 2010
Oct
;18
(10
):432
–8
.
[PubMed]
0966-842X2.
Antonsson
A
, McMillan
NA
. Papillomavirus in healthy skin of Australian animals
. J Gen Virol
. 2006
Nov
;87
(Pt 11
):3195
–200
.
[PubMed]
0022-13173.
Antonsson
A
, Hansson
BG
. Healthy skin of many animal species harbors papillomaviruses which are closely related to their human counterparts
. J Virol
. 2002
Dec
;76
(24
):12537
–42
.
[PubMed]
0022-538X4.
Cubie
HA
. Diseases associated with human papillomavirus infection
. Virology
. 2013
Oct
;445
(1-2
):21
–34
.
[PubMed]
0042-68225.
Bzhalava
D
, Eklund
C
, Dillner
J
. International standardization and classification of human papillomavirus types
. Virology
. 2015
Feb
;476
:341
–4
.
[PubMed]
0042-68226.
Van Doorslaer
K
, Tan
Q
, Xirasagar
S
, Bandaru
S
, Gopalan
V
, Mohamoud
Y
, et al. The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis
. Nucleic Acids Res
. 2013
Jan
;41
(Database issue
):D571
–8
.
[PubMed]
1362-49627.
Bernard
HU
, Burk
RD
, Chen
Z
, van Doorslaer
K
, zur Hausen
H
, de Villiers
EM
. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
. Virology
. 2010
May
;401
(1
):70
–9
.
[PubMed]
0042-68228.
Bouvard
V
, Baan
R
, Straif
K
, Grosse
Y
, Secretan
B
, El Ghissassi
F
, et al.; WHO International Agency for Research on Cancer Monograph Working Group
. A review of human carcinogens—Part B: biological agents
. Lancet Oncol
. 2009
Apr
;10
(4
):321
–2
.
[PubMed]
1470-20459.
Bernard
HU
. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses
. J Clin Virol
. 2005
Mar
;32
Suppl 1
:S1
–6
.
[PubMed]
1386-653210.
Bernard
HU
. Coevolution of papillomaviruses with human populations
. Trends Microbiol
. 1994
Apr
;2
(4
):140
–3
.
[PubMed]
0966-842X11.
Hafner
MS
, Nadler
SA
. Phylogenetic trees support the coevolution of parasites and their hosts
. Nature
. 1988
Mar
;332
(6161
):258
–9
.
[PubMed]
0028-083612.
Gottschling
M
, Stamatakis
A
, Nindl
I
, Stockfleth
E
, Alonso
A
, Bravo
IG
. Multiple evolutionary mechanisms drive papillomavirus diversification
. Mol Biol Evol
. 2007
May
;24
(5
):1242
–58
.
[PubMed]
0737-403813.
Van Doorslaer
K
. Evolution of the papillomaviridae
. Virology
. 2013
Oct
;445
(1-2
):11
–20
.
[PubMed]
0042-682214.
García-Vallvé
S
, Alonso
A
, Bravo
IG
. Papillomaviruses: different genes have different histories
. Trends Microbiol
. 2005
Nov
;13
(11
):514
–21
.
[PubMed]
0966-842X15.
Gottschling
M
, Göker
M
, Stamatakis
A
, Bininda-Emonds
OR
, Nindl
I
, Bravo
IG
. Quantifying the phylodynamic forces driving papillomavirus evolution
. Mol Biol Evol
. 2011
Jul
;28
(7
):2101
–13
.
[PubMed]
0737-403816.
Shah
SD
, Doorbar
J
, Goldstein
RA
. Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling
. Mol Biol Evol
. 2010
Jun
;27
(6
):1301
–14
.
[PubMed]
0737-403817.
Page
RD
, Charleston
MA
. Trees within trees: phylogeny and historical associations
. Trends Ecol Evol
. 1998
Sep
;13
(9
):356
–9
.
[PubMed]
0169-534718.
Angulo
M
, Carvajal-Rodríguez
A
. Evidence of recombination within human alpha-papillomavirus
. Virol J
. 2007
Mar
;4
(1
):33
.
[PubMed]
1743-422X19.
Carvajal-Rodríguez
A
. Detecting recombination and diversifying selection in human alpha-papillomavirus
. Infect Genet Evol
. 2008
Sep
;8
(5
):689
–92
.
[PubMed]
1567-134820.
Varsani
A
, van der Walt
E
, Heath
L
, Rybicki
EP
, Williamson
AL
, Martin
DP
. Evidence of ancient papillomavirus recombination
. J Gen Virol
. 2006
Sep
;87
(Pt 9
):2527
–31
.
[PubMed]
0022-131721.
zur Hausen
H
. Papillomaviruses and cancer: from basic studies to clinical application
. Nat Rev Cancer
. 2002
May
;2
(5
):342
–50
.
[PubMed]
1474-175X22.
Muñoz
N
, Bosch
FX
, de Sanjosé
S
, Herrero
R
, Castellsagué
X
, Shah
KV
, et al.; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
. Epidemiologic classification of human papillomavirus types associated with cervical cancer
. N Engl J Med
. 2003
Feb
;348
(6
):518
–27
.
[PubMed]
0028-479323.
Fehrmann
F
, Laimins
LA
. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation
. Oncogene
. 2003
Aug
;22
(33
):5201
–7
.
[PubMed]
0950-923224.
Bravo
IG
, Alonso
A
. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth
. J Virol
. 2004
Dec
;78
(24
):13613
–26
.
[PubMed]
0022-538X25.
Schiffman
M
, Herrero
R
, Desalle
R
, Hildesheim
A
, Wacholder
S
, Rodriguez
AC
, et al. The carcinogenicity of human papillomavirus types reflects viral evolution
. Virology
. 2005
Jun
;337
(1
):76
–84
.
[PubMed]
0042-682226.
Leechanachai
P
, Banks
L
, Moreau
F
, Matlashewski
G
. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus
. Oncogene
. 1992
Jan
;7
(1
):19
–25
.
[PubMed]
0950-923227.
Valle
GF
, Banks
L
. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells
. J Gen Virol
. 1995
May
;76
(Pt 5
):1239
–45
.
[PubMed]
0022-131728.
Bravo
IG
, Félez-Sánchez
M
. Papillomaviruses: viral evolution, cancer and evolutionary medicine
. Evol Med Public Health
. 2015
Jan
;2015
(1
):32
–51
.
[PubMed]
2050-620129.
Moore
PS
, Chang
Y
. Why do viruses cause cancer? Highlights of the first century of human tumour virology
. Nat Rev Cancer
. 2010
Dec
;10
(12
):878
–89
.
[PubMed]
1474-175X30.
Schiffman
M
, Clifford
G
, Buonaguro
FM
. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
. Infect Agent Cancer
. 2009
Jun
;4
(1
):8
.
[PubMed]
1750-937831.
Mirabello
L
, Yeager
M
, Cullen
M
, Boland
JF
, Chen
Z
, Wentzensen
N
, et al. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women
. J Natl Cancer Inst
. 2016
Apr
;108
(9
):djw100
.
[PubMed]
0027-8874© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
